EDGAR Pro - JANUX THERAPEUTICS, INC.

Welcome

Help

About EDGAR® Online

Recent Companies

Company

Summary

Company Info

Risk Factors
(10-Q 05/08/24)

Auditor Opinion & Info

Company News

Industry

Transcripts

Stock Info

Last Trade
$41.89 (+1.55/3.84%)

Interactive Charting

Financials

Balance Sheet

Income Statement

Cash Flow

Financial Ratios

Financial Comparison

SEC Filings

Last MD&A
(10-Q 05/08/24)

Last Quarterly Filing
(10-Q 05/08/24)

Last Annual Filing
(10-K 03/08/24)

Last Proxy Filing
(DEFA14A 06/17/24)

All Filings
(Excluding Insider)

All Filings

All Quarterly Filings

All Annual Filings

All Proxy Filings

SEC Comment Letters
and Correspondence

Ownership

Summary

Insider Trades

Latest Insider Filings

Institutional Holders

5% Ownership Filings

Company People

Executive Compensation

All Company People

Subscribe Now to unlock all the Features!

Learn More

Get Company Summary for

Add Summary to Dashboard

JANUX THERAPEUTICS, INC. (JANX)

Summary

Latest Filings

View	Form	Filer	Received	Period	Actions
	4	RA CAPITAL HEALTHCARE FUND LP	06/28/24	06/26/24
	4	GUJRATHI SHEILA	06/28/24	06/26/24
	4	MCNULTY ALANA B.	06/28/24	06/26/24
	4	KUNG WINSTON	06/28/24	06/26/24
	4	LICHTER JAY	06/28/24	06/26/24
	4	BARRETT RONALD W	06/28/24	06/26/24
	4	CAPPS VICKIE L	06/28/24	06/26/24
	4	SIMSON JAKE	06/28/24	06/26/24
	8-K	JANUX THERAPEUTICS, INC.	06/28/24	06/26/24
	DEFA14A	JANUX THERAPEUTICS, INC.	06/17/24

Institutional Holders

Total Number of Holders	125
% of Shares Outstanding	81.57%
Total Shares Held	42,294,321
Total Value of Holdings	$1,771,709,106.69
Net Activity	8,738,118

Latest Company News		Date

(Quotes provided by Thomson Reuters are delayed by 15 minutes or more.)

EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Markets Group Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.

EPWWEB-EXT01